GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Z

Zhejiang Shouxiangu Pharmaceutical Co 603896.SS · CNY

Consumer Staples · Shanghai · 🇨🇳 China

Compare

13.64

-0.51%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

About Zhejiang Shouxiangu Pharmaceutical Co

Its shares trade on Shanghai under the ticker 603896.SS. It has been listed since 10 May 2017. In the fiscal year to 31 December 2025, it reported revenue of CN¥640.2m and net income of CN¥18.2m. At that date it held total assets of CN¥3.28bn and shareholders' equity of CN¥2.26bn.

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the breeding, cultivation, processing, and sale of Chinese herbal pieces and health food. The company is headquartered in Jinhua, Zhejiang. The company went IPO on 2017-05-10. The firm's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The firm mainly operates its businesses in domestic markets through wholesaling and direct sales.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Personal Care Products
Listed since
10 May 2017
Employees
1,051
Website
sxg1909.com ↗

Leadership

Pay as last reported

  • Mr. Mingyan LiChairman of the Board, since 2013CN¥826,600
  • Ms. Huizhao ZhuVice Chairman of the Board, since 2013CN¥826,600
  • Mr. Biao ZhuChief Financial Officer
  • Ms. Guofang LiuDeputy General Manager, Company SecretaryCN¥261,100
  • Mr. Rongzhi LinDeputy General Manager, Director, since 2024
  • Mr. Jing XuDeputy General Manager, Director, since 2013CN¥262,700
  • Ms. Huaxian ZhengDeputy General Manager, Director, since 2013CN¥707,100
  • Ms. Yonghong SongDeputy General ManagerCN¥258,400
  • Ms. Ying WangDeputy General ManagerCN¥266,500
  • Mr. Xiaojun LiDirector
  • Mr. Zhenhao LiDirectorCN¥301,800
  • Ms. Zhaowei LiuDirector

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Zhejiang Shouxiangu Pharmaceutical's ganoderma lucidum spore powder is a key product in the Chinese herbal market.
  • The company's 1,051 employees support efficient domestic operations in Jinhua, China.
  • Tiepi Fengdou granule is a leading health food product in the domestic market.

Weaknesses

  • The company's reliance on domestic markets limits international expansion opportunities.
  • Limited product diversity beyond Chinese herbal pieces and health food segments.
  • No mention of international sales channels or global market presence.

Opportunities

  • Growing demand for Chinese herbal products in the domestic health food market.
  • Expanding the fresh dendrobium officinales product line for new market segments.
  • Increasing consumer interest in natural health solutions in China.

Threats

  • Competition from other domestic health food producers in China.
  • Regulatory changes affecting Chinese herbal product standards.
  • Economic downturns impacting consumer spending on health food.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.